ArticleFrontiers in microbiology2023

Serum interleukin-6, procalcitonin, and C-reactive protein at hospital admission can identify patients at low risk for severe COVID-19 progression.

Christian Matthias Zobel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.